BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14675662)

  • 1. Uterine papillary serous carcinomas: the exigency for clinical trials.
    Podratz KC; Mariani A
    Gynecol Oncol; 2003 Dec; 91(3):461-2. PubMed ID: 14675662
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Uterine papillary serous carcinoma].
    Kedzia H; Spaczyński M
    Ginekol Pol; 1994 Oct; 65(10):587-92. PubMed ID: 7729721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
    Woolas RP; Williams K; McCartney AJ
    Gynecol Oncol; 1994 Mar; 52(3):395-401. PubMed ID: 8157198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine papillary serous carcinoma: a new paradigm for treatment?
    Annunziata CM; Kotz HL
    Cancer; 2009 Aug; 115(16):3594-6. PubMed ID: 19452535
    [No Abstract]   [Full Text] [Related]  

  • 7. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
    Lindahl B; Persson J; Ranstam J; Willén R
    Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
    Wang HJ; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):505-7. PubMed ID: 17980094
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
    Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
    J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Uterine papillary serous carcinoma: patterns of metastatic spread.
    Thomas GM
    Gynecol Oncol; 1995 Jun; 57(3):437-8. PubMed ID: 7774855
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
    Ng JS; Han AC; Edelson MI; Rosenblum NG
    Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
    Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
    Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
    Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
    Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uterine papillary serous carcinoma: report of a case].
    Dai L; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):557-8. PubMed ID: 20021972
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uterine papillary serous carcinoma--a different kind of tumor].
    Steinman N; Avni A
    Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
    [No Abstract]   [Full Text] [Related]  

  • 19. Papillary serous carcinoma of the uterus arising in an adenomyoma.
    Griffin M; Parai S; Ghatage P; Dimakulangan A
    Acta Cytol; 1996; 40(4):849-50. PubMed ID: 8693916
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
    Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.